UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sirolimus Therapy Predisposes to New-Onset Diabetes Mellitus After Renal Transplantation: A Long-Term Analysis of Various Treatment Regimens

Transplantation proceedings, 2011-06, Vol.43 (5), p.1583-1592

2011

Volltextzugriff (PDF)

Impact of rituximab therapy for treatment of acute humoral rejection

Clinical transplantation, 2009-01, Vol.23 (1), p.63-73

2009

Volltextzugriff (PDF)

Pharmacology of Synergism Among Immunosuppressive Drugs for Transplantation

Clinical pharmacology and therapeutics, 2011-08, Vol.90 (2), p.303-309

Kahan, BD

2011

Volltextzugriff (PDF)

Fifty Years in the Vineyard of Transplantation: Looking Back

Transplantation proceedings, 2011-10, Vol.43 (8), p.2853-2859

Kahan, B.D

2011

Volltextzugriff (PDF)

Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation: Reviewing Outcomes With De Novo Use of Sirolimus in Combination With Cyclosporine

Transplantation proceedings, 2008-12, Vol.40 (10), p.S17-S20

Kahan, B.D

2008

Volltextzugriff (PDF)

New-Onset Diabetes After Renal Transplantation: Diagnosis, Incidence, Risk Factors, Impact on Outcomes, and Novel Implications

Transplantation proceedings, 2011-06, Vol.43 (5), p.1375-1394

2011

Volltextzugriff (PDF)

Better Actual 10-Year Renal Transplant Outcomes of 80% Reduced Cyclosporine Exposure With Sirolimus Base Therapy Compared With Full Cyclosporine Exposure Without or With Concomittant Sirolimus Treatment

Transplantation proceedings, 2011-12, Vol.43 (10), p.3657-3668

2011

Volltextzugriff (PDF)

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation

Transplantation proceedings, 2003-05, Vol.35 (3), p.S37-S51

Kahan, B.D

2003

Volltextzugriff (PDF)

Frontiers in Immunosuppression

Transplantation proceedings, 2011-04, Vol.43 (3), p.822-825

Kahan, B.D

2011

Volltextzugriff (PDF)

The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?

Kidney international, 2006-09, Vol.70 (6), p.994-999

2006

Volltextzugriff (PDF)

Current Approaches to the Use of Sirolimus In Renal Transplantation

Transplantation proceedings, 2009-10, Vol.41 (8), p.3011-3015

Kahan, B.D

2009

Volltextzugriff (PDF)

Therapeutic drug monitoring of cyclosporine: 20 years of progress

Transplantation proceedings, 2004-03, Vol.36 (2), p.S378-S391

Kahan, B.D

2004

Volltextzugriff (PDF)

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

Transplantation, 2000-05, Vol.69 (10), p.2085

2000

Volltextzugriff (PDF)

Sirolimus: a ten-year perspective

Transplantation proceedings, 2004-01, Vol.36 (1), p.71-75

Kahan, B.D

2004

Volltextzugriff (PDF)

Individualization of Immunosuppressive Therapy. III. Sirolimus Associated With a Reduced Incidence of Malignancy

Transplantation proceedings, 2006-03, Vol.38 (2), p.358-361

2006

Volltextzugriff (PDF)

Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients

Transplantation proceedings, 2003-05, Vol.35 (3), p.S143-S150

2003

Volltextzugriff (PDF)

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation

Clinical pharmacology and therapeutics, 1993-08, Vol.54 (2), p.205-218

1993

Volltextzugriff (PDF)

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

Transplantation, 1998-10, Vol.66 (8), p.1040

1998

Volltextzugriff (PDF)

Addition of induction therapy offsets the hazard of marked calcineurin minimization among renal transplant recipients treated with sirolimus

Clinical nephrology, 2010-05, Vol.73 (5), p.344-353

2010

Volltextzugriff (PDF)

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience

Transplantation proceedings, 2003-05, Vol.35 (3), p.S25-S34

2003

Volltextzugriff (PDF)

Case Report: Successful Treatment of Posttransplant Lymphoproliferative Disorder and Quiescence of Dermatomyositis With Rituximab and Sirolimus

Transplantation proceedings, 2008-06, Vol.40 (5), p.1744-1746

2008

Volltextzugriff (PDF)

Frontiers in Immunosuppression

Transplantation proceedings, 2008, Vol.40 (1), p.11-15

Kahan, B.D

2008

Volltextzugriff (PDF)

Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression

Transplantation, 1999-09, Vol.68 (5), p.701

1999

Volltextzugriff (PDF)

The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

Kidney international, 1996-01, Vol.49 (1), p.209-216

1996

Volltextzugriff (PDF)

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

Transplantation, 1998-07, Vol.66 (1), p.29

1998

Volltextzugriff (PDF)

1 – 25 von 924

Suche als RSS-Feed

Aktive Filter

ThemaRats

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(845)
Mit Volltextzugriff
(413)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(570)
Humans
(558)
Life Sciences & Biomedicine
(548)
Biological And Medical Sciences
(315)
Surgery
(312)
Medical Sciences
(305)
Transplantation
(294)
Immunology
(289)
Female
(229)
Kidney Transplantation
(215)
Pharmacology. Drug Treatments
(200)
Male
(186)
Adult
(184)
Middle Aged
(158)
Immunomodulators
(153)
Animals
(152)
Immunosuppressive Agents - Therapeutic Use
(123)
Kidney Transplantation - Immunology
(93)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(84)
Mice
(77)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Sirolimus Therapy Predisposes to New-Onset Diabetes Mellitus After Renal Transplantation: A Long-Term Analysis of Various Treatment Regimens

Impact of rituximab therapy for treatment of acute humoral rejection

Pharmacology of Synergism Among Immunosuppressive Drugs for Transplantation

Fifty Years in the Vineyard of Transplantation: Looking Back

Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation: Reviewing Outcomes With De Novo Use of Sirolimus in Combination With Cyclosporine

New-Onset Diabetes After Renal Transplantation: Diagnosis, Incidence, Risk Factors, Impact on Outcomes, and Novel Implications

Better Actual 10-Year Renal Transplant Outcomes of 80% Reduced Cyclosporine Exposure With Sirolimus Base Therapy Compared With Full Cyclosporine Exposure Without or With Concomittant Sirolimus Treatment

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation

Frontiers in Immunosuppression

The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?

Current Approaches to the Use of Sirolimus In Renal Transplantation

Therapeutic drug monitoring of cyclosporine: 20 years of progress

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

Sirolimus: a ten-year perspective

Individualization of Immunosuppressive Therapy. III. Sirolimus Associated With a Reduced Incidence of Malignancy

Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

Addition of induction therapy offsets the hazard of marked calcineurin minimization among renal transplant recipients treated with sirolimus

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience

Case Report: Successful Treatment of Posttransplant Lymphoproliferative Disorder and Quiescence of Dermatomyositis With Rituximab and Sirolimus

Frontiers in Immunosuppression

Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression

The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

Aktive Filter

Suchergebnisse filtern